DRTS
Alpha Tau Medical Ltd.
NASDAQ · Healthcare · Biotechnology · IL
$15.24
−1.61%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 415.83x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 31.94x
- Price / sales
- —
- Price / cash flow
- -52.74x
Enterprise value
- Enterprise value
- $1.3B
- EV / sales
- —
- EV / EBITDA
- -26.94x
- EV / EBIT
- -26.21x
- Market cap
- $1.4B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026